Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
The sensitivity, specificity, negative and positive predictive values,... | Download Table
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
PDF) CA 19-9 as a serum marker in urothelial carcinoma
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Download PDF | Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
CA 19-9: Reference Range, Interpretation, Collection and Panels
ROC curves for single detection of CEA (A) and CA 19-9 (B) and combined... | Download Scientific Diagram
CA 19-9 – Pancreatic Cancer Action Network
Clinical Efficacy of Combined Use of CEA-CA19-9 in Patients with Pancreatic Malignancy - SciAlert Responsive Version
Meta-Analysis of Sensitivity and Specificity for CA 19-9 and CEA | Download Table
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/4-Table3-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
The sensitivity, specificity, negative and positive predictive values,... | Download Table
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Download PDF | Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
